The Gene Expression Potential of Chonluten Peptide

Chonluten is a short peptide composed of 3 amino acids proposed as a possible bioregulator of gene expression. It is also known as EDG tripeptide or T-34. Glycine, glutamine, and asparagine are the amino acids that make up this structure in the order of Glu-Asp-Gly.

Chonluten, as suggested by in vitro studies, may originate in the mucosa of the lungs. In that context, Chonluten is thought to restore bronchial mucous membrane cell function by perhaps modulating genes involved in inflammation, antioxidant activity, and proliferation. Studies suggest the peptide may have the potential to enhance cell regeneration in the digestive system.

Chonluten Peptide: Mechanism of Action

Research suggests the peptide may regulate gene expression because of its tiny size, enabling it to enter the cell's nucleus. The nucleosome, histone proteins, and single- and double-stranded DNA may all be accessed by short peptides (containing 2-7 amino acid residues). DNA-peptide interactions are crucial for template-directed synthesis processes, replication, transcription, and repair; this includes sequence recognition in gene promoters. DNA methylation is an epigenetic process that may be activated or repressed by the action of peptides. It's worth noting, however, that the scientists mentioned above only speculated this data on short peptides in general, not Chonluten specifically.

Chonluten Peptide and Inflammation

Scientists hypothesize that in macrophage cells, Chonluten may induce phosphorylation of STAT molecules, in particular STAT1. There is no data that receptor-associated kinases are involved in this activation. The signal transducing and transcription factor STAT1 may work with receptor-associated kinases to promote the nuclear import of biological responses mediated by cytokines.

It has also been hypothesized that Chonluten may inhibit the phosphorylation of STAT3, another transcription factor involved in cellular signaling. A major cytokine in the acute phase response in inflammation and infectious illnesses, IL-6, may be transcribed by the signal transducer and activator of transcription 3 (STAT3). Findings imply that Chonluten's potential to regulate STAT3 phosphorylation suggests it may impact IL-6 transcription and, hence, the inflammatory response.

Additional studies on Chonluten have suggested that it may be useful in reducing lipopolysaccharide (LPS)--activated macrophages' IL-6, TNF, and IL-17 production. LPS is a fragment of bacterial cell walls. Pro-inflammatory cytokines, such as interleukin-6 (IL-6), tumor necrosis factor (TNF), and interleukin-17 (IL-17) all play important roles in immune responses and inflammation. This suggests that Chonluten may have a role in attenuating pro-inflammatory activities in activated macrophages by downregulating the production of these cytokines. The authors speculate, "tripeptide, derived from bronchial epithelial cells, inhibited in vitro tumor necrosis factor (TNF) production of monocytes exposed to pro-inflammatory bacterial lipopolysaccharide (LPS)." Reduced monocyte TNF production is associated with a TNF tolerance mechanism that dampens inflammation.

It has been purported that the adhesion process between endothelium (the lining of blood vessels) and immune cells may also be dampened by Chonluten. This finding emerged from studies using co-incubation of LPS-activated endothelial cells. Chonluten seemed to affect the migration and trafficking of immune cells, which play a vital part in inflammatory and immunological responses, by altering this adhesion process.

Chonluten Peptide and Gastric Cells

Researchers speculate that Chonluten's potential to modulate the expression of genes encoding antioxidant enzymes like superoxide dismutase (SOD) may contribute to its potential to speed up cell regeneration in the gastrointestinal tract. Scientists propose that Chonluten may help restore the equilibrium of antioxidant defense mechanisms in the stomach mucosa since it seems to normalize the expression of these genes. This modulatory impact on antioxidant systems may facilitate cell regeneration and reduce oxidative stress.

The gene expression, such as tumor necrosis factor-alpha (TNF-) and cyclooxygenase-2 (Cox-2), is thought to be regulated by the Chonluten peptide, which may explain its anti-inflammatory impact. The Chonluten peptide may aid stomach mucosal inflammation management by decreasing the expression of inflammatory mediators, hence promoting cell regeneration, studies suggest.

It has been hypothesized that Chonluten may also promote the growth of granulation tissue, which is essential for wound healing. It may aid in repairing injured gastric mucosa by stimulating the proliferation of fibroblasts and the development of blood vessels inside the granulation tissue. In addition, Chonluten seems to stimulate the proliferation of epithelial cells, which may increase the epithelialization of the ulcer and ultimately contribute to the closure of the ulcer defect.

Investigations purport that Chonluten may be helpful by inhibiting uncontrolled cell death (apoptosis) in the stomach lining. Heat shock protein 70 (HSP70) is thought to have a function in shielding cells against apoptotic stimuli, and its expression may be able to be modulated to this end. The peptide's potential to improve tissue survival and repair by regulating HSP70 expression is intriguing.

However, some research has suggested that Chonluten may only have a negligible impact on the growth of certain cell lines, including skin cell lines. Thus, additional study is required to investigate the possible processes and activities of Chonluten.

Buy peptides in the USA from Biotech Peptides if you are a licensed academic interested in further studying the potential of Chonluten peptides in research settings.

References

[i] Avolio, F., Martinotti, S., Khavinson, V. K., Esposito, J. E., Giambuzzi, G., Marino, A., Mironova, E., Pulcini, R., Robuffo, I., Bologna, G., Simeone, P., Lanuti, P., Guarnieri, S., Trofimova, S., Procopio, A. D., & Toniato, E. (2022). Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line. International journal of molecular sciences, 23(7), 3607. https://doi.org/10.3390/ijms23073607

[ii] Khavinson, V. K.h, Lin'kova, N. S., Dudkov, A. V., Polyakova, V. O., & Kvetnoi, I. M. (2012). Peptidergic regulation of expression of genes encoding antioxidant and anti-inflammatory proteins. Bulletin of experimental biology and medicine, 152(5), 615-618.

[iii] Khavinson, V. K., Popovich, I. G., Linkova, N. S., Mironova, E. S., & Ilina, A. R. (2021). Peptide Regulation of Gene Expression: A Systematic Review. Molecules (Basel, Switzerland), 26(22), 7053.

[iv] Khavinson, V. K., Lin'kova, N. S., & Tarnovskaya, S. I. (2016). Short Peptides Regulate Gene Expression. Bulletin of experimental biology and medicine, 162(2), 288-292.

[v] Fedoreyeva, L. I., Kireev, I. I., Khavinson, V. K.h, & Vanyushin, B. F. (2011). Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry. Biokhimiia, 76(11), 1210-1219.

[vi] Voicekhovskaya, M. A., Chalisova, N. I., Kontsevaya, E. A., & Ryzhak, G. A. (2012). Effect of bioregulatory tripeptides on the culture of skin cells from young and old rats. Bulletin of experimental biology and medicine, 152(3), 357-359.